Aveanna Healthcare Holdings Inc. (AVAH) P/E Ratio History
Historical price-to-earnings valuation from 2021 to 2025
Loading P/E history...
Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of March 1, 2026, Aveanna Healthcare Holdings Inc. (AVAH) trades at a price-to-earnings ratio of -129.8x, with a stock price of $7.36 and trailing twelve-month earnings per share of $0.09.
The current P/E is 182% below its 5-year average of 158.2x. Over the past five years, AVAH's P/E has ranged from a low of 66.8x to a high of 339.9x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Healthcare sector median P/E of 23.7x, AVAH trades at a 648% discount to its sector peers. The sector includes 224 companies with P/E ratios ranging from 0.0x to 184.4x.
Relative to the broader market, AVAH trades at a notable discount to the S&P 500 median P/E of 26.2x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our AVAH DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
Peer Comparison
P/E metrics vs. Home-based care services peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
CHEChemed Corporation | $6B | 22.3 | - | -7% |
OPCHOption Care Health, Inc. | $5B | 25.4 | - | +4% |
ADUSAddus HomeCare Corporation | $2B | 19.9 | 0.99Best | +23% |
DCGODocGo Inc. | $73M | 4.0Lowest | - | +177%Best |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
Historical P/E Data
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2025 Q2 | Sat Jun 28 2025 00:00:00 GM | $5.02 | $0.08 | 66.8x | -58% |
| FY2025 Q1 | Sat Mar 29 2025 00:00:00 GM | $5.37 | $0.02 | 339.9x | +115% |
| FY2021 Q2 | Sat Jul 03 2021 00:00:00 GM | $12.47 | $0.18 | 67.8x | -57% |
Average P/E for displayed period: 158.2x
See AVAH's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs AVAH Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare AVAH vs AGIO
See how AVAH stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
Is AVAH stock overvalued or undervalued?
AVAH trades at -129.8x P/E, below its 5-year average of 158.2x. At the N/A percentile of historical range, the stock is priced at a discount to its own history.
How does AVAH's valuation compare to peers?
Aveanna Healthcare Holdings Inc. P/E of -129.8x compares to sector median of 23.7x. The discount suggests lower growth expectations or higher risk.
What is AVAH's PEG ratio?
AVAH PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2021-2025.